YTHDF2 and neoplasm: In papillary thyroid carcinoma (PTC), METTL3 is able to cooperate with YTHDF2 to inhibit IL-8 secretion, reduce tumor-associated neutrophil (TAN) recruitment, and inhibit tumor growth using c-Rel and RelA as downstream modification targets (83).